87 related articles for article (PubMed ID: 9702810)
1. [Dose-dependent inactivation of extracellular human immunodeficiency virus by miramistin].
Krivorutchenko IuL
Vopr Virusol; 1998; 43(3):122-4. PubMed ID: 9702810
[TBL] [Abstract][Full Text] [Related]
2. Antiseptic myramistin possesses the strong anti-HIV properties.
Kryvorutchenko IuL; Kryvosheïn IuS; Andronovs'ka IB; Marennykova SS; Stepanova LH; Nosyk DN; Kalnina LB; Rud'ko AP
Mikrobiol Z; 1996; 58(5):90-2. PubMed ID: 8993062
[TBL] [Abstract][Full Text] [Related]
3. [Study of the anti-HIV activity of miramistin].
Krivorutchenko IuL; KrivosheinIuS ; Marennikova SS; Stepanova LG; Nosik DN; Kalnina LB; Rud'ko AP
Vopr Virusol; 1994; 39(6):267-9. PubMed ID: 7716921
[TBL] [Abstract][Full Text] [Related]
4. [The effect of fetal calf serum on the anti-HIV properties of miramistin].
Krivorutchenko IuL; Krivoshein IuS; Andronovskaia IB; Nosik DN; Kalnina LB; Petrova MS
Vopr Virusol; 1994; 39(6):281-3. PubMed ID: 7716926
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
6. [Effect of saponins from Hedera taurica Carr. and modified muramylpeptides on replication of human immunodeficiency virus in vitro].
Krivorutchenko IuL; Andronovskaia IB; Chirva VIa; Pertel' SS; Grishkovets VI; Zemliakov AE; Kur'ianov VO; Krivoshein IuS
Vopr Virusol; 1997; 42(1):34-6. PubMed ID: 9103043
[TBL] [Abstract][Full Text] [Related]
7. [Prospects of using miramistin for individual prevention of sexual HIV transmission].
Krivorutchenko IuL; Andronovskaia IB
Lik Sprava; 2013 Mar; (2):117-23. PubMed ID: 24605621
[TBL] [Abstract][Full Text] [Related]
8. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of antiviral activity of Myramistin against measles and mumps viruses].
Agafonov AP; Ignat'ev GM; Svistov VV; Smirnov IV; Krivoshein IuS
Antibiot Khimioter; 2005; 50(5-6):17-9. PubMed ID: 16526604
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycin.
Georgiou NA; van der Bruggen T; Oudshoorn M; de Bie P; Jansen CA; Nottet HS; Marx JJ; van Asbeck BS
Antiviral Res; 2004 Aug; 63(2):97-106. PubMed ID: 15302138
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
[TBL] [Abstract][Full Text] [Related]
13. Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells.
Dezube BJ; Ahlers CM; Lawrence JP; Teng EI; Silberman SL; Pardee AB; Finberg RW
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):13-7. PubMed ID: 8989205
[TBL] [Abstract][Full Text] [Related]
14. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H
J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267
[TBL] [Abstract][Full Text] [Related]
15. [The depression of the reproduction of the human immunodeficiency virus by the use of Bogomolets antireticular cytotoxic serum].
Spivak MIa; Karpov OV; Antonenko SV; Barbasheva OV; Kvielienkova KI; Voloshchenko IuV
Mikrobiol Z; 1997; 59(5):57-61. PubMed ID: 9480019
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents.
Burstein ME; Serbin AV; Khakhulina TV; Alymova IV; Stotskaya LL; Bogdan OP; Manukchina EE; Jdanov VV; Sharova NK; Bukrinskaya AG
Antiviral Res; 1999 Apr; 41(3):135-44. PubMed ID: 10320046
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1.
Wainberg MA; Brenner BG; Daar E; Gertner JM; Olivier C; Kenley S
Antimicrob Agents Chemother; 2004 Jun; 48(6):2337-40. PubMed ID: 15155249
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran.
Ghoneum M
Biochem Biophys Res Commun; 1998 Feb; 243(1):25-9. PubMed ID: 9473473
[TBL] [Abstract][Full Text] [Related]
20. Effect of the oral anti-ulcer agent, cimetidine, on HIV type 1 replication.
Bourinbaiar AS; Fruhstorfer EC
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):281-2. PubMed ID: 9071426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
